---
title: "Zhongheng Group subsidiary Lummy received the approval notice for the drug supplementary application"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235598425.md"
description: "Zhongheng Group's holding subsidiary Chongqing Lummy Pharmaceutical has received the notification letter for the supplementary application of Clindamycin Phosphate Injection approved by the National Medical Products Administration, involving two specifications: 2ml: 0.3g and 4ml: 0.6g. This medication is primarily used to treat severe infections caused by sensitive anaerobic bacteria, streptococci, pneumococci, and staphylococci"
datetime: "2025-04-11T10:50:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235598425.md)
  - [en](https://longbridge.com/en/news/235598425.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235598425.md)
generator: "portal-rs"
---

# Zhongheng Group subsidiary Lummy received the approval notice for the drug supplementary application

According to the Zhitong Finance APP, Zhongheng Group (600252.SH) announced that its holding subsidiary Chongqing Lummy Pharmaceutical Co., Ltd. (hereinafter referred to as "Lummy Pharmaceutical") has received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration for two specifications of Clindamycin Phosphate Injection: 2ml: 0.3g and 4ml: 0.6g.

Clindamycin Phosphate Injection is mainly suitable for severe infections caused by sensitive anaerobic bacteria, streptococci, pneumococci, and sensitive strains of staphylococci, as well as specified sensitive microorganisms

### Related Stocks

- [300006.CN](https://longbridge.com/en/quote/300006.CN.md)
- [600252.CN](https://longbridge.com/en/quote/600252.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Sentinel Net Lease Announces Final Closing of Sentinel Opportunity Fund I](https://longbridge.com/en/news/296631028.md)
- [SpaceX has some of the world's biggest investors on board. Meet 10 of its top shareholders.](https://longbridge.com/en/news/296512739.md)
- [OncoZenge registers 772,797 shares in directed issue after SEK 5 million payment from Sichuan Yangtian](https://longbridge.com/en/news/296607308.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**